Clinical and molecular analysis of common MEFV gene mutations in familial Mediterranean fever in Sivas population

Al-Alami J.R., Tayeh M.K., Najib D.A., Abu-Rubaiha Z.A., Majeed H.A., Al-Khateeb M.S. & El-Shanti H.I. 2003. Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med. J. 24: 1055–1059. Aldea A., Calafell F., Aróstegui J.I., Lao O., Rius J., Plaza S., Masó M., Vives J., Buades J. & Yagüe J. 2004. The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination “hotspot” at the MEFV locus. Hum. Mutat. 23: 399–406. Ben-Chetrit E. & Levy M. 1998. Familial Mediterranean fever. Lancet 351: 659–664. Chae J.J., Komarow H.D., Cheng J., Wood G., Raben N., Liu P.P. & Kastner D.L. 2003. Targeted disruption of pyrin, the FMF protein causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol. Cell. 11: 591–604. Chae J.J., Wood G., Masters S.L., Richard K., Park G., Smith B.J. & Kastner D.L. 2006. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production. Proc. Natl. Acad. Sci. USA 103: 9982–9987. Centola M., Wood G., Frucht D.M., Galon J., Aringer M., Farrell C., Kingma D.W., Horwitz M.E., Mansfield E., Holland S.M., O’shea J.J., Rosenberg H.F., Malech H.L. & Kastner D.L. 2000. The gene for familial Mediterranean fever, MEFV, is expressed in early leucocyte development and is regulated in response to inflammatory mediators. Blood 95: 3223–3231. Chen X., Fischel-Ghodsian N., Cercek A., Hamon M., Ogur G., Lotan R., Danon Y. & Shohat M. 1998. Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF). Hum. Mutat. 11: 456–460. Deltas C.C., Mean R., Rossou E., Costi C., Koupepidou P., Hadjiyanni I., Hadjiroussos V., Petrou P., Pierides A., Lamnisou K. & Koptides M. 2002. Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus. Genet. Test. 6: 15–21. Dewalle M., Domingo C., Rozenbaum M., Ben-Chétrit E., Cattan D., Bernot A., Dross C., Dupont M., Notarnicola C., Levy M., Rosner I., Demaille J. & Touitou I. 1998. Phenotypegenotype correlation in Jewish patients suffering from familial Mediterranean Fever (FMF). Eur. J. Hum. Genet. 6: 95–97. Ertekin V., Selimoğlu M.A. & Pirim I. 2005. Familial Mediterranean fever in a childhood population in eastern Turkey. Pediatr. Int. 47: 640–644. Goulielmos G.N., Fragouli E., Aksentijevich I., Sidiropoulos P., Boumpas D.T. & Eliopoulos E. 2006. Mutational analysis of the PRYSPRY domain of pyrin and implications for familial Mediterranean fever (FMF). Biochem. Biophys. Res. Commun. 345: 1326–1332. La Regina M., Nucera G., Diaco M., Procopio A., Gasbarrini G., Notarnicola C., Kone-Paut I., Touitou I. & Manna R. 2003. Familial Mediterranean fever is no longer a rare disease in Italy. Eur. J. Hum. Genet. 11: 50–56. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., Migdal A., Padeh S. & Pras M. 1997. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40: 1879–1885. Majeed H.A., Carroll J.E., Khuffash F.A. & Hijazi Z. 1990. Longterm colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis). J. Pediatr. 116: 997–999. Majeed H.A., El-Khateeb M., El-Shanti H., Rabaiha Z.A., Tayeh M. & Najib D. 2005. The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. Semin. Arthritis Rheum. 34: 813–818. Medlej-Hashim M., Serre J.L., Corbani S., Saab O., Jalkh N., Delague V., Chouery E., Salem N., Loiselet J., Lefranc G. & Mégarbané A. 2005. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur. J. Med. Genet. 48: 412–420. Mor A., Shinar Y., Zaks N., Langevitz P., Chetrit A., Shtrasburg S., Rabinovitz E. & Livneh A. 2005. Evaluation of disease severity in familial Mediterranean fever. Semin. Arthritis Rheum.35: 57–64. Odabas A.R., Cetinkaya R., Selcuk Y. & Bilen H. 2002. Familial Mediterranean fever. South. Med. J. 95: 1400–1403. Onen F., Sumer H., Turkay S., Akyurek O., Tunca M. & Ozdogan H. 2004. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin. Exp. Rheumatol. 22: 31–34. Ozer F.L, Kaplaman E. & Zileli S. 1971. Familial Mediterranean fever in Turkey: a report of twenty cases. Am. J. Med. 50: 336–339. Pras M. 1998. Familial Mediterranean fever: from the clinical syndrome to the cloning of pyrin gene. Scand. J. Rheumatol. 27: 92–97. Pras M., Bronshpigel N., Zemer D. & Gafni J. 1982. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med. J. 150: 22–26. Rogers D.B., Shohat M., Petersen G.M., Bickal J., Congleton J., Schwabe A.D. & Rotter J.I. 1989. Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency. Am. J. Med. Genet. 34: 168–172. Samli H., Dogru O., Bukulmez A., Yuksel E., Ovali F. & Solak M. 2006. Relationship of Tel-Hashomer criteria and Mediterranean gene mutation in cohort of Turkish familial Mediterranean fever patients. Saudi Med. J. 27: 1822–1826. Sarkisian T., Ajrapetyan H. & Shahsuvaryan G. 2005. Molecular study of FMF patients in Armenia. Curr. Drug Targets Inflamm. Allergy 4: 113–116. Sayarlioglu M., Cefle A., Inanc M., Kamali S., Dalkilic E., Gul A., Ocal L., Aral O. & Konice M. 2005. Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int. J. Clin. Pract. 59: 202–205. Sohar E., Gafni J., Pras M. & Heller H. 1967. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am. J. Med. 43: 227–253. Stoffman N., Magal N., Shohat T., Lotan R., Koman S., Oron A., Danon Y., Halpern G.J., Lifshitz Y. & Shohat M. 2000. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur. J. Hum. Genet. 8: 307–310. The French FMF Consortium. 1997. A candidate gene for familial Mediterranean fever. Nat. Genet. 17: 25–31. The International FMF Consortium. 1997. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797–807. Touitou I. 2001. The spectrum of familial Mediterranean fever (FMF) mutations. Eur. J. Hum. Genet. 9: 473–483. Touitou I., Lesage S., McDermott M., Cuisset L., Hoffman H., Dode C., Shoham N., Aganna E., Hugot J.P., Wise C., Waterham H., Pugnere D., Demaille J. & Sarrauste de Menthiere C. 2004. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum. Mutat. 24: 194–198. Tunca M., Akar S., Onen F., Ozdogan H., Kasapcopur O., Yalcinkaya F., Tutar E., Ozen S., Topaloglu R., Yilmaz E., Arici M., Bakkaloglu A., Besbas N., Akpolat T., Dinc A. & Erken E; Turkish FMF Study Group. 2005. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 84: 1–11. Yilmaz E., Ozen S., Balci B., Duzova A., Topaloglu R., Besbas N., Saatci U., Bakkaloglu A. & Ozguc M. 2001. Mutation frequency of familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur. J. Hum. Genet. 9: 553–555. Zaks N., Shinar Y, Padeh S., Lidar M., Mor A., Tokov I., Pras M., Langevitz P., Pras E. & Livneh A. 2003. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Med. Assoc. J. 5: 585–588. Zemer D., Livneh A., Danon Y.L., Pras M. & Sohar E. 1991. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum. 34: 973–977.